These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 18293897)
1. Calix[4]arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation. Geraci C; Consoli GM; Galante E; Bousquet E; Pappalardo M; Spadaro A Bioconjug Chem; 2008 Mar; 19(3):751-8. PubMed ID: 18293897 [TBL] [Abstract][Full Text] [Related]
2. First self-adjuvant multicomponent potential vaccine candidates by tethering of four or eight MUC1 antigenic immunodominant PDTRP units on a calixarene platform: synthesis and biological evaluation. Geraci C; Consoli GM; Granata G; Galante E; Palmigiano A; Pappalardo M; Di Puma SD; Spadaro A Bioconjug Chem; 2013 Oct; 24(10):1710-20. PubMed ID: 24041198 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen. Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen. Vichier-Guerre S; Lo-Man R; Huteau V; Dériaud E; Leclerc C; Bay S Bioorg Med Chem Lett; 2004 Jul; 14(13):3567-70. PubMed ID: 15177475 [TBL] [Abstract][Full Text] [Related]
6. Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer. Wilkinson BL; Day S; Malins LR; Apostolopoulos V; Payne RJ Angew Chem Int Ed Engl; 2011 Feb; 50(7):1635-9. PubMed ID: 21308921 [No Abstract] [Full Text] [Related]
7. Synthesis and immunological evaluation of N-acyl modified Tn analogues as anticancer vaccine candidates. Song C; Sun S; Huo CX; Li Q; Zheng XJ; Tai G; Zhou Y; Ye XS Bioorg Med Chem; 2016 Feb; 24(4):915-20. PubMed ID: 26787275 [TBL] [Abstract][Full Text] [Related]
8. A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates. Lo-Man R; Vichier-Guerre S; Perraut R; Dériaud E; Huteau V; BenMohamed L; Diop OM; Livingston PO; Bay S; Leclerc C Cancer Res; 2004 Jul; 64(14):4987-94. PubMed ID: 15256473 [TBL] [Abstract][Full Text] [Related]
9. Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates. De Silva RA; Wang Q; Chidley T; Appulage DK; Andreana PR J Am Chem Soc; 2009 Jul; 131(28):9622-3. PubMed ID: 19552408 [TBL] [Abstract][Full Text] [Related]
10. Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen. Buskas T; Ingale S; Boons GJ Angew Chem Int Ed Engl; 2005 Sep; 44(37):5985-8. PubMed ID: 16108081 [No Abstract] [Full Text] [Related]
11. Conjugation, immunoreactivity, and immunogenicity of calix[4]arenes; model study to potential calix[4]arene-based Ac3+ chelators. Grote Gansey MH; de Haan AS; Bos ES; Verboom W; Reinhoudt DN Bioconjug Chem; 1999; 10(4):613-23. PubMed ID: 10411459 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of selected LeY and KH-1 analogues: a medicinal chemistry approach to vaccine optimization. Spassova MK; Bornmann WG; Ragupathi G; Sukenick G; Livingston PO; Danishefsky SJ J Org Chem; 2005 Apr; 70(9):3383-95. PubMed ID: 15844973 [TBL] [Abstract][Full Text] [Related]
13. Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligand. Abdel-Aal AB; El-Naggar D; Zaman M; Batzloff M; Toth I J Med Chem; 2012 Aug; 55(15):6968-74. PubMed ID: 22800462 [TBL] [Abstract][Full Text] [Related]
14. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance. Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of a non-natural T-antigen containing glycosphingolipid. Cipolla L; Meldal M Carbohydr Lett; 2000; 4(1):29-34. PubMed ID: 11469335 [TBL] [Abstract][Full Text] [Related]
16. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis. Longenecker BM; Reddish M; Koganty R; MacLean GD Adv Exp Med Biol; 1994; 353():105-24. PubMed ID: 7527178 [TBL] [Abstract][Full Text] [Related]
17. Tn antigen analogues: the synthetic way to "upgrade" an attracting tumour associated carbohydrate antigen (TACA). Nativi C; Papi F; Roelens S Chem Commun (Camb); 2019 Jul; 55(54):7729-7736. PubMed ID: 31225574 [TBL] [Abstract][Full Text] [Related]
18. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination. Freire T; Lo-Man R; Piller F; Piller V; Leclerc C; Bay S Glycobiology; 2006 May; 16(5):390-401. PubMed ID: 16449349 [TBL] [Abstract][Full Text] [Related]
19. Total synthesis of the potential anticancer vaccine KH-1 adenocarcinoma antigen. Deshpande PP; Danishefsky SJ Nature; 1997 May; 387(6629):164-6. PubMed ID: 9144285 [TBL] [Abstract][Full Text] [Related]
20. Syntheses and Immunological Evaluation of Self-Adjuvanting Clustered N-Acetyl and N-Propionyl Sialyl-Tn Combined with a T-helper Cell Epitope as Antitumor Vaccine Candidates. Chang TC; Manabe Y; Fujimoto Y; Ohshima S; Kametani Y; Kabayama K; Nimura Y; Lin CC; Fukase K Angew Chem Int Ed Engl; 2018 Jul; 57(27):8219-8224. PubMed ID: 29768704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]